CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $66,000 | -93.5% | 398,945 | -90.1% | 0.00% | -100.0% |
Q2 2022 | $1,016,000 | -74.5% | 4,029,171 | -46.3% | 0.00% | -25.0% |
Q1 2022 | $3,992,000 | +59.3% | 7,509,908 | +84.5% | 0.00% | -20.0% |
Q4 2021 | $2,506,000 | -38.6% | 4,070,006 | +1.7% | 0.01% | -50.0% |
Q3 2021 | $4,081,000 | -54.4% | 4,000,237 | -18.2% | 0.01% | -60.0% |
Q2 2021 | $8,948,000 | +33.7% | 4,889,571 | +44.0% | 0.02% | +8.7% |
Q1 2021 | $6,691,000 | +161.1% | 3,396,393 | +65.7% | 0.02% | +130.0% |
Q4 2020 | $2,563,000 | +61.9% | 2,050,102 | +133.1% | 0.01% | +25.0% |
Q3 2020 | $1,583,000 | -74.4% | 879,595 | +19.5% | 0.01% | -78.4% |
Q2 2020 | $6,177,000 | +76.9% | 736,288 | +10.5% | 0.04% | +37.0% |
Q1 2020 | $3,492,000 | -2.6% | 666,414 | +1.5% | 0.03% | +22.7% |
Q4 2019 | $3,585,000 | -34.7% | 656,340 | -41.8% | 0.02% | -42.1% |
Q3 2019 | $5,488,000 | -26.3% | 1,126,812 | +4.8% | 0.04% | -25.5% |
Q2 2019 | $7,451,000 | – | 1,075,170 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |